JP2010521488A5 - - Google Patents

Download PDF

Info

Publication number
JP2010521488A5
JP2010521488A5 JP2009553789A JP2009553789A JP2010521488A5 JP 2010521488 A5 JP2010521488 A5 JP 2010521488A5 JP 2009553789 A JP2009553789 A JP 2009553789A JP 2009553789 A JP2009553789 A JP 2009553789A JP 2010521488 A5 JP2010521488 A5 JP 2010521488A5
Authority
JP
Japan
Prior art keywords
composition
dose
tur
administration
bladder cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009553789A
Other languages
English (en)
Japanese (ja)
Other versions
JP5788143B2 (ja
JP2010521488A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/056912 external-priority patent/WO2008112934A1/en
Publication of JP2010521488A publication Critical patent/JP2010521488A/ja
Publication of JP2010521488A5 publication Critical patent/JP2010521488A5/ja
Application granted granted Critical
Publication of JP5788143B2 publication Critical patent/JP5788143B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009553789A 2007-03-13 2008-03-13 癌を処置するための経尿道的切除術後の膀胱内アパジクオン投与 Expired - Fee Related JP5788143B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89461007P 2007-03-13 2007-03-13
US60/894,610 2007-03-13
PCT/US2008/056912 WO2008112934A1 (en) 2007-03-13 2008-03-13 Intravesical apaziquone administration following transurethral resection for treating cancer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013203128A Division JP2014028841A (ja) 2007-03-13 2013-09-30 癌を処置するための経尿道的切除術後の膀胱内アパジクオン投与

Publications (3)

Publication Number Publication Date
JP2010521488A JP2010521488A (ja) 2010-06-24
JP2010521488A5 true JP2010521488A5 (enExample) 2011-04-21
JP5788143B2 JP5788143B2 (ja) 2015-09-30

Family

ID=39494173

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009553789A Expired - Fee Related JP5788143B2 (ja) 2007-03-13 2008-03-13 癌を処置するための経尿道的切除術後の膀胱内アパジクオン投与
JP2013203128A Pending JP2014028841A (ja) 2007-03-13 2013-09-30 癌を処置するための経尿道的切除術後の膀胱内アパジクオン投与

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013203128A Pending JP2014028841A (ja) 2007-03-13 2013-09-30 癌を処置するための経尿道的切除術後の膀胱内アパジクオン投与

Country Status (17)

Country Link
US (1) US20080227841A1 (enExample)
EP (1) EP2134322B1 (enExample)
JP (2) JP5788143B2 (enExample)
KR (1) KR20090128479A (enExample)
CN (1) CN101677942B (enExample)
AR (1) AR065732A1 (enExample)
AU (1) AU2008224962B2 (enExample)
BR (1) BRPI0808804A2 (enExample)
CA (1) CA2680481C (enExample)
ES (1) ES2727257T3 (enExample)
IL (1) IL200899A0 (enExample)
MX (1) MX2009009777A (enExample)
NZ (1) NZ579609A (enExample)
RU (2) RU2480200C2 (enExample)
TW (1) TWI434684B (enExample)
WO (1) WO2008112934A1 (enExample)
ZA (1) ZA200906328B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201213486D0 (en) * 2012-07-30 2012-09-12 Univ Salford The Quinone compounds and their uses for the treatment of cancer
WO2014062856A1 (en) 2012-10-16 2014-04-24 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2178305C1 (ru) * 2000-11-02 2002-01-20 Гарбер Александр Григорьевич Ирригационный раствор
ATE493126T1 (de) * 2001-11-01 2011-01-15 Spectrum Pharmaceuticals Inc Medizinische zusammensetzungen zur intravesikalen behandlung von blasenkrebs
RU2002121829A (ru) * 2002-08-07 2004-02-27 Сгму Способ лечения местнораспространенных форм рака мочевого пузыря

Similar Documents

Publication Publication Date Title
Kim et al. Ceria‐based therapeutic antioxidants for biomedical applications
JP2022121594A5 (enExample)
JP2012502015A5 (enExample)
CN103030140A (zh) 透明质酸修饰的氧化石墨烯及其药物组合物的制备方法与应用
JP2008044951A5 (enExample)
JP2012520866A5 (enExample)
JP2012529488A5 (enExample)
Hu et al. N-acetyl-galactosamine modified metal-organic frameworks to inhibit the growth and pulmonary metastasis of liver cancer stem cells through targeted chemotherapy and starvation therapy
CN102264347A (zh) 灌肠制剂及其应用
JP2009506054A5 (enExample)
Wang et al. Peptide‐based supramolecular therapeutics for fighting major diseases
CN102370638B (zh) 3,3’-二吲哚甲烷及衍生物在制备治疗肝脏疾病药物中的应用
TW202133883A (zh) 新多功能寡肽
JP2009517411A5 (enExample)
US20070060622A1 (en) Compositions and methods using proton pump inhibitors
JP5680412B2 (ja) レオヌリンの使用およびその組成物
Hasan et al. Localized drug delivery in different gastrointestinal cancers: navigating challenges and advancing nanotechnological solutions
JP2012525358A5 (enExample)
WO2024169525A1 (zh) 含硼药物及其制备方法
JP2010521488A5 (enExample)
JP2009516719A5 (enExample)
JP2006514665A5 (enExample)
JP2013507382A5 (enExample)
KR102008826B1 (ko) 나토키나제와 항염증제를 유효성분으로 포함하는 혈소판 응집 억제용 또는 혈전용해용 의약 조성물
JP2019530718A5 (enExample)